retatrutide clinical trial dose escalation A Clinician's Guide to Dosing Retatrutide Results After 40: Realistic

Abubakar M, Nama L, Ansari MA, Ansari MM, Bhardwaj S, Daksh R, Syamala KLV, Jamadade MS, Chhabra V, Kumar D, Kumar N (2024) GLP-1/GIP Agonist as an Intriguing and Ultimate Remedy for Combating Alzheimers Disease through its Supporting DPP4 Inhibitors: A Review

Conclusions Future studies will provide further insights to refine the role of these new drugs, continuing to expand their utility beyond T2D, to treat renalcardiometabolic conditions in a more integrated approach as a single entity to target

EBioMedicine 93:104642 Arans C, Caffrey A, Edvardsson CE et al (2025) Synergistic-like decreases in alcohol intake following combined pharmacotherapy with GLP-1 and Amylin in male rats

The study found that peripheral endothelial dysfunction independently correlated with future cardiovascular events, thus providing additional clinical significance for risk stratification in HFpEF patients

Despite the declines, GLP-1 users reported a continued desire to consume processed foods, sodas, refined grains and beef

The goal is having a rhythm you can repeat when your appetite is tiny and decision-making feels like one more dish in the sink